Abstracts tagged "Sjogren’s syndrome and autoimmune diseases"

Abstract Number: 1488 • 2013 ACR/ARHP Annual Meeting
Gene Expression Profile According To Systemic Disease Activity In Primary Sjögren’s Syndrome: Results From The Assessment Of Systemic Signs and Evolution Of Primary Sjögren’s Syndrome (ASSESS) Cohort
Nawal Rahal¹, Nicolas Cagnard², Ghada Alsaleh³, Raphaèle Seror⁴, Corinne Miceli-Richard⁵, Joelle Benessiano⁶, Philippe Dieude⁷, Jean Jacques Dubost⁸, Anne-Laure Fauchais⁹, Vincent Goeb¹⁰, Eric Hachulla¹¹, Pierre-Yves Hatron¹², C. Larroche¹³, Véronique le Guern¹⁴, Jacques Morel¹⁵, Aleth Perdriger¹⁶, Xavier Puechal¹⁷, Stephanie Rist¹⁸, Alain Saraux¹⁹, Damien Sene²⁰, Jean Sibilia²¹, Olivier Vittecoq²², Philippe Ravaud²³, Xavier Mariette²⁴ and Jacques-Eric Gottenberg²¹, ¹Strasbourg University Hospital, STRASBOURG, France, ²Institut Cochin, 75014 Paris, France, ³Univerity of Strasbourg, STRASBOURG, France, ⁴Rheumatology, Bicetre university hospital, LE Kremlin-Bicetre, France, ⁵Rheumatology Department, Université Paris-Sud 11, Bicêtre Hospital,, Kremlin Bicêtre, France, ⁶Rheumatology, Paris Unervisity Hospital BICHAT, Paris, France, ⁷Rheumatology, Rheumatology departement & INSERM U699, Paris Diderot university, APHP, Bichat hospital, Paris, France, ⁸Rheumatology, CHU G.-Montpied, Clermont-Ferrand, France, ⁹Department of Internal Medicine A, Dupuytren Hospital, Limoges University Hospital, Limoges, France, ¹⁰Rheumatology, Amiens University Hospital, Amiens, France, ¹¹Internal Medicine, Lille CEDEX, France, ¹²Department of Internal Medicine, Claude Huriez University Hospital, Lille, France, ¹³Hospital University Bobigny, bobigny, France, ¹⁴Department of Internal Medicine, Hôpital Cochin, Paris, France, ¹⁵Montpellier University Hospital, Montpellier, France, ¹⁶Rheumatology, Hôpital Sud, Rennes, France, ¹⁷Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, ¹⁸Rheumatology, Orleans Hospital, Orleans, France, ¹⁹Rhumatologie, CHU de la Cavale Blanche, Brest Cedex, France, ²⁰Internal Medicine, Hopital Lariboisière, Paris, France, ²¹Division of Rheumatology, University Hospital of Strasbourg, Strasbourg, France, ²²Rheumatology, Rouen University Hospital & Inserm905, University of Rouen, Rouen Cedex, France, ²³Epidemiology, Hopital Hotel Dieu, Paris Descartes University, Paris, France, ²⁴Paris-Sud University, Paris, France
Background/Purpose: In primary Sjögren’s syndrome (pSS), the pathogenesis of systemic complications remains unclear. Only few gene expression studies were performed and concerned a limited number…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].